KleihauerBetke test is used to detect
So the core concept here is the detection of fetal hemoglobin, which is different from adult hemoglobin. The Kleihauer-Betke test uses a specific staining technique where fetal hemoglobin resists acid, making the cells appear pink under the microscope. The main clinical use is to estimate the amount of fetal blood loss in a mother, which helps in calculating the necessary dose of Rh immunoglobulin to prevent Rh sensitization in Rh-negative mothers.
Now, the correct answer should be the option that states detecting fetal hemoglobin in maternal blood. The other options might include things like detecting other types of hemoglobin (like sickle cell), measuring Rh factor, or something else. Let me think about the wrong options. Option A could be detecting sickle cell trait, which uses a different test. Option B might be measuring maternal hemoglobin levels, which isn't the purpose here. Option C could be testing for Rh compatibility, but that's usually done with a blood test, not the Kleihauer-Betke method. Option D might be unrelated, like detecting fetal anemia, but that's a different scenario.
For each incorrect option, I need to explain why they're wrong. For example, if an option says it's for Rh typing, the Kleihauer-Betke test isn't used for that. It's specifically about quantifying fetal hemoglobin. The clinical pearl here is that the test is crucial for Rh-negative mothers to prevent hemolytic disease of the newborn by determining the correct dose of Rh immunoglobulin. The high-yield fact is that fetal hemoglobin (HbF) is resistant to acid elution, which is the basis of the test. I should make sure to mention that the test helps estimate the volume of fetal blood in the mother, which relates to the number of Rh immunoglobulin units needed. Also, the correct answer is the one that mentions fetal hemoglobin detection in maternal blood. Let me structure this into the required sections now.
**Core Concept**
The Kleihauer-Betke test detects **fetal hemoglobin (HbF)** in maternal blood. It is used to estimate the volume of fetal blood lost during pregnancy or delivery, critical for calculating the required dose of **Rh immunoglobulin (RhIg)** in RhD-negative mothers to prevent Rh alloimmunization.
**Why the Correct Answer is Right**
The test relies on the acid-elution principle: fetal RBCs retain HbF, which resists acid, while maternal RBCs (containing adult hemoglobin) lose their hemoglobin and appear pale. By quantifying fetal RBCs under a microscope, it determines the **fetal-maternal hemorrhage (FMH)** volume. This is vital to administer the correct RhIg dose, as underdosing can fail to prevent Rh sensitization, risking hemolytic disease of the newborn (HDN).
**Why Each Wrong